Literature DB >> 2171962

The use of Xenopus oocytes to evaluate drugs affecting brain Ca2+ channels: effects of bifemelane and several nootropic agents.

S Kaneko1, H Takahashi, M Satoh.   

Abstract

Effects of nootropic or cerebroprotective drugs on voltage-sensitive Ca2+ channels (VSCC) in the mammalian brain were evaluated comparatively by depolarization-evoked Ca2+ channel currents in Xenopus oocytes injected with brain mRNA and by a high K(+)-stimulated 45Ca uptake into synaptosomes. It was found that several anti-amnesic agents (bifemelane, idebenone and vinpocetine) inhibited these VSCC-related responses with stronger potency than phenytoin and flurazepam. On the inhibiting potency of various compounds, there was a significant but weak correlation between the results from synaptosomes and those from the injected oocytes, since nifedipine, verapamil and diltiazem at 100 microM did not reduce 45Ca influx in synaptosomes but partly inhibited VSCCs in the oocytes. The blockade of neuronal L- and N-type VSCCs may participate in the anti-ischemic/hypoxic actions of nootropic drugs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2171962     DOI: 10.1016/0922-4106(90)90229-q

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  Vinpocetine selectively inhibits neurotransmitter release triggered by sodium channel activation.

Authors:  M Sitges; V Nekrassov
Journal:  Neurochem Res       Date:  1999-12       Impact factor: 3.996

2.  Nootropic agent vinpocetine blocks delayed rectified potassium currents more strongly than high-threshold calcium currents.

Authors:  E I Solntseva
Journal:  Neurosci Behav Physiol       Date:  1998 Mar-Apr

3.  Vinpocetine inhibits NF-kappaB-dependent inflammation via an IKK-dependent but PDE-independent mechanism.

Authors:  Kye-Im Jeon; Xiangbin Xu; Toru Aizawa; Jae Hyang Lim; Hirofumi Jono; Dong-Seok Kwon; Jun-Ichi Abe; Bradford C Berk; Jian-Dong Li; Chen Yan
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-06       Impact factor: 11.205

4.  The nootropic drug vinpocetine inhibits veratridine-induced [Ca2+]i increase in rat hippocampal CA1 pyramidal cells.

Authors:  T Zelles; L Franklin; I Koncz; B Lendvai; G Zsilla
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

Review 5.  Idebenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in age-related cognitive disorders.

Authors:  J C Gillis; P Benefield; D McTavish
Journal:  Drugs Aging       Date:  1994-08       Impact factor: 3.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.